Esaote S.p.A. – sole-shareholder company(English)
UroFusion TPUS/TRUS Smart Prostate Target Biopsy June 2022, Genova, Italy.
2022 | NaviSuite®
Abstract To evaluate the diagnostic accuracy of mpMRI and mpMRI / transrectal ultrasound (TRUS) fusion-guided targeted biopsy (FTB) against…
2018 | BiopSee®
Magnetic Resonance and Ultrasound Image Fusion Supported Transperineal Prostate Biopsy Using the Ginsburg Protocol: Technique, Learning Points, and…
2016 | BiopSee®
E. Romero-Selas, V. Cuadros, J. Montáns, E. Sánchez, J.M. López-Alcorocho, F. Gómez-Sancha (Spanish)
Transperineal prostate biopsy with ECHO-MRI fusion. Biopsee system. Initial experience
2016 | BiopSee®
TRANSPERINEAL SATURATION/FUSION BIOPSIES INTEGRATION IN HIFU PROSTATE FOCAL TREATMENT BY FOCAL ONE®
2016 | BiopSee®
Prostate Cartography: Targeted &systematic perineal stereotactic prostate biopsy using the BiopSee®platform in locating and re-locating prostate…
2016 | BiopSee®
Purpose: Diagnosis and precise risk stratification of prostate cancer (PC) is essential for individualized treatment decisions. MRI/TRUS fusion has…
2013 | BiopSee®
MRT-navigierte stereotaktische Prostatabiopsie – Echtzeitfusion von MRT und transrektalem Ultraschall zu perinealen Prostatastanzbiopsien.
The interest in fusion imaging technology for transcranial application, that is the registration of Echo-color Doppler Ultrasound (ECD) and a second…

